DK2311466T3 - Antimicrobial compositions and methods for their application - Google Patents

Antimicrobial compositions and methods for their application Download PDF

Info

Publication number
DK2311466T3
DK2311466T3 DK10184218.5T DK10184218T DK2311466T3 DK 2311466 T3 DK2311466 T3 DK 2311466T3 DK 10184218 T DK10184218 T DK 10184218T DK 2311466 T3 DK2311466 T3 DK 2311466T3
Authority
DK
Denmark
Prior art keywords
group
composition
compounds
alkyl
protonated
Prior art date
Application number
DK10184218.5T
Other languages
Danish (da)
English (en)
Inventor
Roderic M K Dale
Steven L Gatton
Amy Arrow
Terry Thompson
Original Assignee
Lakewood Amedex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lakewood Amedex Inc filed Critical Lakewood Amedex Inc
Application granted granted Critical
Publication of DK2311466T3 publication Critical patent/DK2311466T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing acyclic or cycloaliphatic radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dermatology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
DK10184218.5T 2001-05-03 2002-05-03 Antimicrobial compositions and methods for their application DK2311466T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/847,654 US20020032164A1 (en) 1998-12-30 2001-05-03 Antimicrobial compounds and methods for their use
EP02734149A EP1389909B1 (en) 2001-05-03 2002-05-03 Antimicrobial compounds and methods for their use

Publications (1)

Publication Number Publication Date
DK2311466T3 true DK2311466T3 (en) 2015-10-19

Family

ID=25301163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10184218.5T DK2311466T3 (en) 2001-05-03 2002-05-03 Antimicrobial compositions and methods for their application

Country Status (10)

Country Link
US (2) US20020032164A1 (US06780888-20040824-C00057.png)
EP (2) EP2311466B1 (US06780888-20040824-C00057.png)
JP (4) JP4347573B2 (US06780888-20040824-C00057.png)
AU (1) AU2002305336B2 (US06780888-20040824-C00057.png)
CA (2) CA2445381C (US06780888-20040824-C00057.png)
CY (1) CY1116784T1 (US06780888-20040824-C00057.png)
DK (1) DK2311466T3 (US06780888-20040824-C00057.png)
ES (1) ES2549766T3 (US06780888-20040824-C00057.png)
PT (1) PT2311466E (US06780888-20040824-C00057.png)
WO (1) WO2002089581A1 (US06780888-20040824-C00057.png)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627215B1 (en) * 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
EP2351765A3 (en) * 2001-07-10 2012-02-22 Lakewood-Amedex, Inc Oligonucleotide-containing pharmacological compositions and their use
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
WO2005011592A2 (en) * 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indazole-o-glucosides
AR045173A1 (es) 2003-08-01 2005-10-19 Tanabe Seiyaku Co Compuestos que poseen actividad inhibitoria contra transportador de glucosa dependiente de sodio
TW200727785A (en) * 2005-11-25 2007-08-01 Maruishi Pharma Gel composition for antibacterial sterilization
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
ES2675045T3 (es) * 2007-05-04 2018-07-06 Symrise Ag Preparaciones activas sinérgicas que comprenden 1,2-decanodiol y además compuestos activos antimicrobianos
WO2009035969A1 (en) * 2007-09-10 2009-03-19 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of sglt
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
GB2460445B (en) * 2008-05-30 2012-07-11 Vernolix Ltd Treatment of ringworm
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
EP2451797B1 (en) 2009-07-10 2013-04-03 Janssen Pharmaceutica, N.V. CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE
WO2011047113A1 (en) * 2009-10-14 2011-04-21 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
CN108354930A (zh) 2010-05-11 2018-08-03 詹森药业有限公司 包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的药物制剂
HUE030116T2 (en) 2011-04-13 2017-04-28 Janssen Pharmaceutica Nv A method for preparing compounds useful as inhibitors of SGLT2
TWI542596B (zh) 2011-05-09 2016-07-21 健生藥品公司 （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
BR112019018615B1 (pt) 2017-03-10 2021-11-16 Lakewood Amedex, Inc. Composto antimicrobiano e sua composiqao farmaceutica
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11377468B2 (en) 2017-03-10 2022-07-05 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
EP3638251B1 (en) 2017-06-12 2024-03-06 Lakewood Amedex, Inc. Bisphosphocin gel formulations and uses thereof
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
AU2019361999A1 (en) 2018-10-17 2021-02-25 Lakewood Amedex, Inc. Methods and compositions for treating oral mucositis
CZ308943B6 (cs) * 2019-12-12 2021-09-22 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipofosfonoxiny třetí generace, jejich příprava a použití
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
KR20220009630A (ko) * 2020-07-16 2022-01-25 정준영 플라즈마를 이용한 마스크 폐기 처리기

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
DE2916318A1 (de) * 1979-04-23 1980-11-06 Hoechst Ag Waesserige desinfektionsloesung
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4908209A (en) * 1983-08-16 1990-03-13 Interface, Inc. Biocidal delivery system of phosphate ester and method of preparation thereof
JPS60209077A (ja) * 1984-03-27 1985-10-21 竹本油脂株式会社 繊維処理用油剤及び該油剤による合成繊維糸の処理方法
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
DE3542516A1 (de) 1985-12-02 1987-06-04 Henkel Kgaa Desinfektionsmittel
WO1989001023A1 (en) * 1987-08-03 1989-02-09 Interface Research Corporation Microbiocidal cleansing or disinfecting formulations and preparation thereof
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
ZA902710B (en) 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5420330A (en) * 1990-09-07 1995-05-30 Pharmacia P-L Biochemicals Inc. Lipo-phosphoramidites
WO1992010504A2 (en) * 1990-12-07 1992-06-25 The Upjohn Company Phosphonic acid derivatives useful as antiinflammatory agents
US5681829A (en) * 1992-10-08 1997-10-28 Shaman Pharmaceuticals, Inc. Class of phosphocholine derivatives having antifungal activity
US5811568A (en) * 1992-10-08 1998-09-22 Shaman Pharmaceuticals, Inc. Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
AU5354494A (en) * 1992-10-08 1994-05-09 Shaman Pharmaceuticals, Inc. Novel class of phosphocholine derivatives having antifungal activity
DE4333385C2 (de) 1993-09-30 1997-01-30 Friedrich A Spruegel Flächendesinfektions- und Reinigungsmittel
FR2718022B1 (fr) 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2727289B1 (fr) * 1994-11-30 1999-03-05 Derives Resiniques Terpenique Composition desinfectante comprenant au moins un alcool terpenique et au moins un tensio-actif acide bactericide, et utilisation de tels tensio-actifs
CA2238484A1 (en) * 1995-11-28 1997-06-05 Michael D. Wider Antimicrobial composition and methods of use therefor
US5843998A (en) 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US6211349B1 (en) * 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US6610314B2 (en) * 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations

Also Published As

Publication number Publication date
JP2005511482A (ja) 2005-04-28
EP2311466A3 (en) 2012-04-25
US7176191B2 (en) 2007-02-13
EP1389909A4 (en) 2005-03-30
ES2549766T3 (es) 2015-11-02
EP1389909A1 (en) 2004-02-25
JP5503900B2 (ja) 2014-05-28
US20050107344A1 (en) 2005-05-19
CY1116784T1 (el) 2017-03-15
CA2445381C (en) 2013-09-17
EP2311466B1 (en) 2015-07-08
CA2827671A1 (en) 2002-11-14
JP4347573B2 (ja) 2009-10-21
JP2014055139A (ja) 2014-03-27
EP1389909B1 (en) 2012-07-18
JP6097372B2 (ja) 2017-03-15
AU2002305336B2 (en) 2007-11-08
JP2016056177A (ja) 2016-04-21
PT2311466E (pt) 2015-10-27
EP2311466A2 (en) 2011-04-20
WO2002089581A1 (en) 2002-11-14
CA2445381A1 (en) 2002-11-14
JP5883838B2 (ja) 2016-03-15
JP2009179639A (ja) 2009-08-13
CA2827671C (en) 2016-07-05
US20020032164A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
DK2311466T3 (en) Antimicrobial compositions and methods for their application
US7868162B2 (en) Antimicrobial and antiviral compounds and methods for their use
AU2002305336A1 (en) Antimicrobial compounds and methods for their use
DE69931809T2 (de) Antibakterielle protonierte oligonukleotide
US4873265A (en) Anti-infective methods and compositions
AU755003B2 (en) Topical antiseptic compositions and methods
EP0105448B1 (en) The use of undecylenic acid for the manufacture of a composition for the treatment of herpes labialis
AU2013276985B2 (en) Antimicrobial and antiviral compounds and methods for their use
EP2704730B1 (en) Avian-based treatment for microbial infections
US4897404A (en) Anti-infective methods and compositions
US4895857A (en) Anti-infective methods and compositions
ZA200604768B (en) Disinfecting composition and methods of making and using same